PHA Preceptorship Program: A Collaborative Approach for Clinicians on the Front Line

Developed by the PHA Scientific Leadership Council, this program offers, at nationally recognized PAH centers, direct instruction on state-of-the-art PAH diagnosis and management for physicians and other health professionals who help care for patients with PAH.

These day-long highly interactive preceptorships build links among community PAH specialists, non-specialists, and clinicians at established PAH centers, creating new avenues for communication and more comprehensive, state-of-the-art diagnosis, initial treatment, and long-term management of patients with PAH.

  • All programs are scheduled from 9:00 a.m. – 3:30 p.m.
  • A complimentary breakfast and lunch are provided
  • This program is FREE

Target Audience

This activity has been designed for pulmonologists, cardiologists, rheumatologists, internists, and primary care physicians, as well as nurses, physician assistants, and other allied health professionals who help care for patients with PAH.

Educational Objectives

The PHA Preceptorship Program is designed to improve competence, performance, and patient care practices by instructing front-line clinicians in the highest quality of care for patients with PAH by combining didactic discourse and highly interactive case-based discussion. At the conclusion of this program, participants should be able to:

  • Define key pathophysiologic and epidemiologic components of PAH
  • Accurately diagnose patients through comprehensive screening and early recognition of symptoms
  • Evaluate the patient’s condition and prescribe optimal long-term management, including knowing when and how to treat and when to consult with colleagues at an established PAH center
  • Tailor comprehensive care for complex patient populations

Accreditation and Credit Designation

This live activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Washington University School of Medicine in St. Louis, Continuing Medical Education and the Pulmonary Hypertension Association. Washington University is accredited by the ACCME to provide continuing medical education for physicians.

Washington University designates this live activity for a maximum of 5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Statement

It is the policy of Washington University School of Medicine in St. Louis, Continuing Medical Education, that planners, faculty and other persons who may influence content of this CME activity disclose all relevant financial relationships with commercial interests in order for CME staff to identify and resolve any potential conflicts of interest prior to the educational activity. Faculty must also disclose any planned discussion of off-label/unapproved uses of drugs or devices during their presentation. Detailed disclosures will be made in activity handout materials.

Registration is now open for these programs:

Palo Alto, Calif – July 21, 2017
Chapel Hill, N.C. – August 25, 2017
Jacksonville, Fla. – September 8, 2017
Dallas, Texas – October 13, 2017
Indianapolis, Ind. – November 3, 2017

Register now

And planning is underway for programs in:

Baltimore, Md.
Boston, Mass.
Minneapolis, Minn.
Nashville, Tenn.
New York, N.Y. (For Pediatricians)

Completed Programs:

Sept. 30, 2016 Washington, D.C.
Oct. 21, 2016 Ann Arbor, Mich.
Oct. 28, 2016 Pittsburgh, Pa.
Nov. 4, 2016 New York, N.Y.
Nov. 4, 2016 San Diego (La Jolla), Calif.
Nov. 11, 2016 Orlando (Celebration), Fla.
Nov. 11, 2016 Milwaukee (Wauwatosa), Wis.
Dec. 2, 2016 Birmingham, Ala.
Dec. 9, 2016 Houston, Texas (For Pediatricians)
Dec. 9, 2016 Philadelphia, Pa.

For more information, or to be informed when the locations are announced, please email Medical@PHAssociation.org.

Accreditation and Credit Designation

This live activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Washington University School of Medicine in St. Louis, Continuing Medical Education and the Pulmonary Hypertension Association. Washington University is accredited by the ACCME to provide continuing medical education for physicians.

Washington University designates this live activity for a maximum of 5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

University of Michigan Medical School

This activity is jointly provided by Washington University School of Medicine in St. Louis, Continuing Medical Education and the Pulmonary Hypertension Association.

DIAMOND
SUPPORTER

PLATINUM
SUPPORTERS

Actelion Pharmaceuticals US, Inc. Gilead Sciences, Inc.
United Therapeutics Corporation
This is a program of the PHA Medical Education Fund, made possible through educational grants from our supporters.